Background
Methods
Study cohort
Measurement methods
ISAR
CGA
Health outcome variables
Statistical analysis
Results
Study cohort
Demographic and medical data
Total (n = 547) | ISAR- (n = 229; 41.9%) | ISAR+/CGA normal (n = 145; 26.5%) | ISAR+/CGA abnormal (n = 97; 17.7%) | p-value ISAR+/CGA normal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR+/CGA normal | |
---|---|---|---|---|---|---|---|
Age (years) | 78.1 ± 6.0 | 77.9 ± 5.4 | 77.0 ± 5.9 | 80.5 ± 6.5 | 0.259 |
0.001
|
<0.001
|
Sex (male) | 299 (54.7) | 122 (53.3) | 96 (66.2) | 43 (44.3) |
0.013
| 0.118 |
<0.001
|
Anemia | 152 (27.8) | 55 (24.0) | 51 (35.2) | 29 (29.9) |
0.019
| 0.336 | 0.318 |
Chronic kidney disease | 240 (43.9) | 86 (37.6) | 75 (51.7) | 43 (44.3) |
0.007
| 0.327 | 0.194 |
Heart failure | 106 (19.4) | 39 (17.0) | 35 (24.1) | 16 (16.5) | 0.140 | 0.999 | 0.263 |
Coronary heart disease | 213 (38.9) | 90 (39.3) | 51 (35.2) | 45 (46.4) | 0.511 | 0.329 | 0.142 |
Atrial fibrillation | 174 (31.8) | 62 (27.1) | 47 (32.4) | 37 (38.1) | 0.293 |
0.050
| 0.412 |
Other cardiac arrhythmias | 70 (12.8) | 23 (10.0) | 18 (12.4) | 17 (17.5) | 0.498 | 0.097 | 0.354 |
Valve insufficiency | 196 (35.8) | 78 (34.1) | 53 (36.6) | 39 (40.2) | 0.738 | 0.213 | 0.423 |
Chronic obstructive pulmonary disease | 69 (12.6) | 25 (10.9) | 17 (11.7) | 15 (15.5) | 0.867 | 0.277 | 0.448 |
Peripheral artery disease | 76 (13.9) | 27 (11.8) | 22 (15.2) | 21 (21.6) | 0.348 |
0.040
| 0.237 |
Arterial hypertension | 430 (78.6) | 175 (76.4) | 113 (77.9) | 80 (82.5) | 0.704 | 0.311 | 0.626 |
Diabetes | 171 (31.3) | 71 (31.0) | 45 (31.0) | 33 (34.0) | 0.999 | 0.606 | 0.676 |
Hyperlipoproteinemia | 269 (49.2) | 96 (41.9) | 79 (54.5) | 55 (56.7) |
0.025
|
0.011
| 0.694 |
Nicotine abuse | 82 (15.0) | 34 (14.8) | 25 (17.2) | 11 (11.3) | 0.561 | 0.484 | 0.202 |
Obesity | 116 (21.2) | 46 (20.1) | 29 (20.0) | 23 (23.7) | 0.999 | 0.463 | 0.427 |
History of myocardial infarction | 56 (10.2) | 23 (10.0) | 9 (6.2) | 13 (13.4) | 0.255 | 0.443 | 0.073 |
History of pulmonary embolism | 11 (2.0) | 2 (0.9) | 4 (2.8) | 3 (3.1) | 0.378 | 0.070 | 0.447 |
History of stroke | 56 (10.2) | 14 (6.1) | 16 (11.0) | 15 (15.5) | 0.116 |
0.006
| 0.255 |
History of thrombosis | 49 (9.0) | 19 (8.3) | 10 (6.9) | 12 (12.4) | 0.695 | 0.306 | 0.179 |
Hyperthyroidism | 24 (4.4) | 15 (6.6) | 1 (0.7) | 5 (5.2) |
0.007
| 0.802 |
0.042
|
Hypothyroidism | 84 (15.4) | 30 (13.1) | 30 (20.7) | 11 (11.3) | 0.081 | 0.859 | 0.118 |
Dementia | 37 (6.8) | 4 (1.7) | 9 (6.2) | 16 (16.5) | 0.067 |
<0.001
|
0.005
|
Alcohol abuse | 19 (3.5) | 6 (2.6) | 7 (4.8) | 2 (2.1) | 0.261 | 0.999 | 0.317 |
Depression | 30 (5.5) | 9 (3.9) | 5 (3.4) | 7 (7.2) | 0.999 | 0.265 | 0.236 |
Anxiety disorder | 2 (0.4) | 1 (0.4) | 0 (0.0) | 0 (0.0) | 0.999 | 0.999 | 0.999 |
Parkinson’s disease | 6 (1.1) | 3 (1.3) | 2 (1.4) | 0 (0.0) | 0.999 | 0.557 | 0.515 |
Polyneuropathy | 40 (7.3) | 13 (5.7) | 10 (6.9) | 14 (14.4) | 0.825 |
0.009
|
0.028
|
Cancer | 215 (39.3) | 89 (38.9) | 73 (50.3) | 21 (21.6) |
0.041
|
0.003
|
<0.001
|
Cataract | 33 (6.0) | 8 (3.5) | 13 (9.0) | 6 (6.2) |
0.036
| 0.371 | 0.472 |
Presbycusis | 21 (3.8) | 8 (3.5) | 4 (2.8) | 7 (7.2) | 0.773 | 0.161 | 0.128 |
Anal incontinence | 3 (0.5) | 1 (0.4) | 2 (1.4) | 0 (0.0) | 0.562 | 0.999 | 0.515 |
Urinary incontinence | 4 (0.7) | 1 (0.4) | 0 (0.0) | 2 (2.1) | 0.999 | 0.218 | 0.165 |
Pressure ulcers | 24 (4.4) | 1 (0.4) | 4 (2.8) | 14 (14.4) | 0.075 |
<0.001
|
0.002
|
Rheumatism | 24 (4.4) | 11 (4.8) | 5 (3.4) | 4 (4.1) | 0.609 | 0.999 | 0.999 |
Total (n = 547) | ISAR- (n = 229) | ISAR+/CGA normal (n = 145) | ISAR+/CGA abnormal (n = 97) | |
---|---|---|---|---|
Liver cancer | 71 (13.0) | 30 (13.1) | 25 (17.2) | 5 (5.2) |
Renal transplantation | 55 (10.1) | 15 (6.5) | 24 (16.6) | 9 (9.3) |
CKD (not dialysis-dependent) | 38 (6.9) | 17(7.4) | 10 (6.9) | 4 (4.3) |
Peripheral artery disease | 30 (5.5) | 16 (7.0) | 7 (4.8) | 6 (6.2) |
Aortic valve stenosis | 25 (4.6) | 6 (2.6) | 4 (2.8) | 9 (9.3) |
CKD requiring dialysis | 21 (3.8) | 11 (4.8) | 8 (5.5) | 0 (0.0) |
Arterial hypertension | 19 (3.5) | 12 (5.2) | 3 (2.1) | 2 (2.1) |
Acute renal failure | 19 (3.5) | 7 (3.1) | 3 (2.1) | 5 (5.2) |
Heart failure | 17 (3.1) | 6 (2.6) | 3 (2.1) | 5 (5.2) |
Neoplasia of the gastrointestinal tract | 14 (2.6) | 9 (3.9) | 4 (2.8) | 0 (0.0) |
Cholangiocarcinoma | 13 (2.4) | 6 (2.6) | 3 (2.1) | 1 (1.0) |
Liver cirrhosis | 10 (1.8) | 3 (1.3) | 5 (3.4) | 1 (1.0) |
Cholangitis | 8 (1.5) | 4 (1.7) | 1 (0.7) | 1 (1.0) |
ST-segment elevation myocardial infarction | 8 (1.5) | 3 (1.3) | 1 (0.7) | 2 (2.1) |
Aneurysm | 8 (1.5) | 8 (3.5) | 0 (0.0) | 0 (0.0) |
Angina pectoris | 8 (1.5) | 5 (2.2) | 1 (0.7) | 0 (0.0) |
Vasculitides | 8 (1.5) | 1 (0.4) | 4 (2.8) | 1 (1.0) |
Infectious diseases | 7 (1.3) | 0 (0.0) | 3 (2.1) | 3 (3.1) |
Diverticulosis | 7 (1.3) | 3 (1.3) | 1 (0.7) | 3 (3.1) |
Non-ST-segment elevation myocardial infarction | 7 (1.3) | 4 (1.7) | 0 (0.0) | 2 (2.1) |
Mitral valve stenosis or insufficiency | 7 (1.3) | 2 (0.9) | 1 (0.7) | 4 (4.3) |
Bile duct strictures | 6 (1.1) | 3 (1.3) | 1 (0.7) | 0 (0.0) |
Aortic dissection | 6 (1.1) | 2 (0.9) | 1 (0.7) | 2 (2.1) |
Cholelithiasis | 5 (0.9) | 3 (1.3) | 1 (0.7) | 1 (1.0) |
Gastrointestinal bleeding | 5 (0.9) | 4 (1.7) | 0 (0.0) | 0 (0.0) |
Pancreatic cysts | 5 (0.9) | 3 (1.3) | 1 (0.7) | 0 (0.0) |
Urinary tract infection | 4 (0.8) | 0 (0.0) | 1 (0.7) | 2 (2.1) |
ISAR screening and CGA results
Sensitivity and specificity analyses of different ISAR cutoffs for the prediction of length of hospital stay, nursing hours and physiotherapy
Sensitivity and specificity analyses of different CGA abnormal definitions for the prediction of needs (length of hospital stay, nursing hours and physiotherapy)
Sensitivity (true positive rate) | Specificity (true negative rate) | 1-Specificity (false positive rate) | Youden’s J (true positive - false positive rate) | |
---|---|---|---|---|
Impairment of ADL plus another domain | 0.493 | 0.730 | 0.270 | 0.223 |
Alternative definition A: Impairment of ADL plus cognition impairment or signs of depression | 0.415 | 0.790 | 0.210 | 0.205 |
Alternative definition B: Impairment of ADL plus mobility impairment | 0.364 | 0.818 | 0.182 | 0.182 |
Sensitivity (true positive rate) | Specificity (true negative rate) | 1-Specificity (false positive rate) | Youden’s J (true positive - false positive rate) | |
---|---|---|---|---|
Impairment of ADL plus another domain | 0.556 | 0.731 | 0.269 | 0.286 |
Alternative definition A: Impairment of ADL plus cognition impairment or signs of depression | 0.741 | 0.798 | 0.202 | 0.539 |
Alternative definition B: Impairment of ADL plus mobility impairment | 0.364 | 0.818 | 0.182 | 0.182 |
Sensitivity (true positive rate) | Specificity (true negative rate) | 1-Specificity (false positive rate) | Youden’s J (true positive - false positive rate) | |
---|---|---|---|---|
Impairment of ADL plus another domain | 0.651 | 0.730 | 0.270 | 0.381 |
Alternative definition A: Impairment of ADL plus cognition impairment or signs of depression | 0.566 | 0.792 | 0.208 | 0.358 |
Alternative definition B: Impairment of ADL plus mobility impairment | 0.457 | 0.797 | 0.203 | 0.254 |
Associations of ISAR and CGA results with health outcome (length of hospital stay, nursing and physiotherapy hours, incident fall and type of discharge)
ISAR- (n = 229; 48.6%) | ISAR+/CGA normal (n = 143; 30.4%) | ISAR+/CGA abnormal (n = 99; 21.0%) | p-value ISAR+/CGA normal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR- | p-value ISAR+/CGA abnormal vs ISAR+/CGA normal | |
---|---|---|---|---|---|---|
Treatment terminated regularly | 179 (78.2%) | 113 (78.5%) | 59 (59.6%) | 0.056 | 0.133 |
0.002
|
Treatment terminated regularly, post-treatment planned | 34 (14.8%) | 17 (11.8%) | 19 (19.2%) | 0.097 | 0.715 | 0.073 |
Treatment terminated against medical advice | 2 (0.9%) | 0 (0.0%) | 2 (2.0%) | 0.999 | 0.999 | 0.438 |
Transfer to another hospital | 6 (2.6%) | 7 (4.9%) | 10 (10.1%) | 0.753 | 0.086 | 0.280 |
Death | 4 (1.7%) | 2 (1.4%) | 3 (3.0%) | 0.531 | 0.592 | 0.190 |
Discharge to rehabilitation institution | 0 (0.0%) | 3 (2.1%) | 2 (2.0%) | 0.137 | 0.098 | 0.999 |
Discharge to nursing institution | 0 (0.0%) | 0 (0.0%) | 2 (2.0%) | 0.999 | 0.315 | 0.438 |
Discharge or transfer with subsequent readmission | 4 (1.7%) | 1 (0.7%) | 2 (2.0%) | 0.999 | 0.677 | 0.999 |